Cargando…
Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ
Serial monitoring of plasma DNA mutations in estrogen receptor positive metastatic breast cancer (ER + MBC) holds promise as an early predictor of therapeutic response. Here, we developed dPCR-SEQ, a customized assay that utilizes digital PCR-based target enrichment followed by next-generation seque...
Autores principales: | Kumar, Sunil, Lindsay, Daniel, Chen, Q. Brent, Garrett, Amy L., Tan, Xianming M., Anders, Carey K., Carey, Lisa A., Gupta, Gaorav P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281679/ https://www.ncbi.nlm.nih.gov/pubmed/30534596 http://dx.doi.org/10.1038/s41523-018-0093-3 |
Ejemplares similares
-
dPCR: A Technology Review
por: Quan, Phenix-Lan, et al.
Publicado: (2018) -
qPCR, dPCR, NGS – A journey
por: Huggett, Jim F., et al.
Publicado: (2015) -
PCR inhibition in qPCR, dPCR and MPS—mechanisms and solutions
por: Sidstedt, Maja, et al.
Publicado: (2020) -
Comparison among the Quantification of Bacterial Pathogens by qPCR, dPCR, and Cultural Methods
por: Ricchi, Matteo, et al.
Publicado: (2017) -
Rapid and ultrasensitive digital PCR (dPCR) profiling of EGFRvIII in tumor cells and tissues
por: Saxena, Deeksha, et al.
Publicado: (2019)